Company Filing History:
2 out of 15,471 
2 out of 1,080 
2 out of 3 Years Active: 2022-2025
Title: The Innovative Contributions of Benjamin VanderSluis
Introduction
Benjamin VanderSluis is a notable inventor based in New York, NY (US). He has made significant strides in the field of cancer research through his innovative patents. With a total of 2 patents, VanderSluis is recognized for his contributions to targeting cancer cells using genetically modified immune cells.
Latest Patents
VanderSluis's latest patents focus on systems and methods for targeting cancer cells. One of his key inventions provides immune cells that are genetically modified to produce two antigen-triggered polypeptides. Each polypeptide recognizes a different cell surface antigen, enhancing the ability to target cancer cells effectively. The disclosure includes methods for killing target cancer cells using these genetically modified immune cells and systems. Additionally, it outlines a computational method to identify target antigen pairs on cancer cells, further advancing the field of cancer treatment.
Career Highlights
Throughout his career, VanderSluis has worked with prestigious institutions such as the University of California and Princeton University. His work has been instrumental in developing innovative approaches to cancer therapy, showcasing his commitment to improving patient outcomes through scientific research.
Collaborations
VanderSluis has collaborated with esteemed colleagues, including Wendell A Lim and Olga G Troyanskaya. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Benjamin VanderSluis is a pioneering inventor whose work in targeting cancer cells has the potential to revolutionize cancer treatment. His innovative patents and collaborations with leading researchers highlight his significant contributions to the field.